?
Gleckel Louis Md
Director
ProPhase Labs, Inc.
US, Garden City [HQ]
CIK
1164762
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
98,590
Price per Share :
$0.60
Equivalence :
$59,154.00
Transaction History
-
A98,590 Shares After TransactionValue : $234,644.20$11,250.26Transaction Date : 07/01/19
-
Footnotes
-
-
Footnotes:#1 These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.
-
A223,840 Shares After TransactionValue : $320,091.20$11,265.54Transaction Date : 07/01/20
-
Footnotes
-
-
Footnotes:#1 These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees.
-
P209,894 Shares After TransactionValue : $367,314.50$175,000.00Transaction Date : 03/26/20
-
Footnotes
-
-
Footnotes:No footnote found.
-
A109,894 Shares After TransactionValue : $221,985.88$11,239.28Transaction Date : 01/01/20
-
Footnotes
-
-
Footnotes:#1 These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees.
-
A104,330 Shares After TransactionValue : $204,486.80$11,250.40Transaction Date : 10/01/19
-
Footnotes
-
-
Footnotes:#1 These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees.